161 related articles for article (PubMed ID: 22022477)
21. Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids.
Blázquez-García I; Guerrero L; Cacho-Navas C; Djouder N; Millan J; Paradela A; Carmona-Rodríguez L; Corrales FJ
J Proteome Res; 2024 Apr; 23(4):1433-1442. PubMed ID: 38488493
[TBL] [Abstract][Full Text] [Related]
22. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
Sancho P; Mainez J; Crosas-Molist E; Roncero C; Fernández-Rodriguez CM; Pinedo F; Huber H; Eferl R; Mikulits W; Fabregat I
PLoS One; 2012; 7(9):e45285. PubMed ID: 23049784
[TBL] [Abstract][Full Text] [Related]
23. Cholesterol Induces Nrf-2- and HIF-1
Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O
Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088
[TBL] [Abstract][Full Text] [Related]
24. Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis.
Hohenester S; Kanitz V; Kremer AE; Paulusma CC; Wimmer R; Kuehn H; Denk G; Horst D; Elferink RO; Beuers U
Cells; 2020 Jan; 9(2):. PubMed ID: 31979271
[TBL] [Abstract][Full Text] [Related]
25. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration.
Malato Y; Sander LE; Liedtke C; Al-Masaoudi M; Tacke F; Trautwein C; Beraza N
Hepatology; 2008 Jun; 47(6):2036-50. PubMed ID: 18393321
[TBL] [Abstract][Full Text] [Related]
27. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
28. Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.
Mair M; Zollner G; Schneller D; Musteanu M; Fickert P; Gumhold J; Schuster C; Fuchsbichler A; Bilban M; Tauber S; Esterbauer H; Kenner L; Poli V; Blaas L; Kornfeld JW; Casanova E; Mikulits W; Trauner M; Eferl R
Gastroenterology; 2010 Jun; 138(7):2499-508. PubMed ID: 20193684
[TBL] [Abstract][Full Text] [Related]
29. A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death.
Catrysse L; Farhang Ghahremani M; Vereecke L; Youssef SA; Mc Guire C; Sze M; Weber A; Heikenwalder M; de Bruin A; Beyaert R; van Loo G
Cell Death Dis; 2016 Jun; 7(6):e2250. PubMed ID: 27253414
[TBL] [Abstract][Full Text] [Related]
30. IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver.
Luedde T; Heinrichsdorff J; de Lorenzi R; De Vos R; Roskams T; Pasparakis M
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9733-8. PubMed ID: 18606991
[TBL] [Abstract][Full Text] [Related]
31. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
32. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
[TBL] [Abstract][Full Text] [Related]
33. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA.
McDaniel K; Wu N; Zhou T; Huang L; Sato K; Venter J; Ceci L; Chen D; Ramos-Lorenzo S; Invernizzi P; Bernuzzi F; Wu C; Francis H; Glaser S; Alpini G; Meng F
Hepatology; 2019 Jun; 69(6):2562-2578. PubMed ID: 30723922
[TBL] [Abstract][Full Text] [Related]
35. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
Voshol PJ; Koopen NR; de Vree JM; Havinga R; Princen HM; Elferink RP; Groen AK; Kuipers F
J Hepatol; 2001 Feb; 34(2):202-9. PubMed ID: 11281547
[TBL] [Abstract][Full Text] [Related]
36. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
[TBL] [Abstract][Full Text] [Related]
37. Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation.
Sunami Y; Leithäuser F; Gul S; Fiedler K; Güldiken N; Espenlaub S; Holzmann KH; Hipp N; Sindrilaru A; Luedde T; Baumann B; Wissel S; Kreppel F; Schneider M; Scharffetter-Kochanek K; Kochanek S; Strnad P; Wirth T
Hepatology; 2012 Sep; 56(3):1117-28. PubMed ID: 22407857
[TBL] [Abstract][Full Text] [Related]
38. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
[TBL] [Abstract][Full Text] [Related]
39. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
40. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
